No abstract available
Publication types
-
Case Reports
-
Comment
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Amsacrine / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Autoimmune Diseases / complications
-
Autoimmune Diseases / therapy*
-
Blast Crisis / complications
-
Blast Crisis / drug therapy
-
Blast Crisis / therapy*
-
Bone Marrow Transplantation*
-
Carmustine / administration & dosage
-
Combined Modality Therapy
-
Cytarabine / administration & dosage
-
Etoposide / administration & dosage
-
Female
-
Humans
-
Idarubicin / administration & dosage
-
Immunologic Factors / therapeutic use
-
Interferon-alpha / therapeutic use
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
-
Lupus Erythematosus, Systemic / complications
-
Lupus Erythematosus, Systemic / drug therapy
-
Lupus Erythematosus, Systemic / therapy*
-
Methotrexate / administration & dosage
-
Prednisone / administration & dosage
-
Remission Induction
-
Transplantation, Autologous
-
Vincristine / administration & dosage
Substances
-
Immunologic Factors
-
Interferon-alpha
-
Amsacrine
-
Cytarabine
-
Vincristine
-
Etoposide
-
Carmustine
-
Prednisone
-
Methotrexate
-
Idarubicin